Charts AbbVie Inc.

Stocks

ABBV

US00287Y1091

Pharmaceuticals

Delayed NYSE 16:03:55 2026-09-04 EDT			5-day change	1st Jan Change
256.46 ^USD	-1.44%		+0.38%	+12.24%

09-03	AbbVie Announces Positive Topline Results From The Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate And Progression-Free Survival In Patients With Relapsed/Refractory Multiple Myeloma	CI
09-03	AbbVie Inc. completed the acquisition of Apogee Therapeutics, Inc. from Fairmount Healthcare Fund II L.P managed by Fairmount Funds Management LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P managed by Venrock Management, LLC and other shareholders.	CI

Chart: Technical Analysis

NYSEUSD

Markets		Quality
NYSE	ABBV	Delayed
CBOE	ABBV	Real-time
Mexican S.E.	ABBV *	End-of-day quote
Tradegate	4AB	Real-time
Borsa Italiana	1ABBV	End-of-day quote
Börse Stuttgart	4AB	Delayed
Boerse Muenchen	4AB	Real-time
Xetra	4AB	Delayed
CBOE		Real-time
Deutsche Boerse AG	4AB	Delayed
Swiss Exchange	ABBV	Delayed
London S.E.	0QCV	Delayed
Wiener Boerse	ABBV	End-of-day quote
CBOE	0QCV	Real-time
Santiago S.E.	ABBV	End-of-day quote
Santiago S.E.	ABBVCL	End-of-day quote
Swiss Exchange	ABBV	Delayed
Buenos Aires S.E.	ABBVD	End-of-day quote
Buenos Aires S.E.	ABBV	End-of-day quote
Toronto S.E.	ABBV	Delayed
Deutsche Boerse AG	4AB0	Delayed
Thailand S.E.	ABBV19	End-of-day quote
Thailand S.E.	ABBV80	End-of-day quote

ProRealTime Chart

Technical analysis trends

	Short Term	Mid-Term	Long Term
Trend	Bullish	Bullish	Bullish
Resistance	265.97	265.97	264.96
Spread/Res.	-3.58%	-3.58%	-3.21%
Spread/Supp.	+1.25%	+12.62%	+12.62%
Support	253.3	227.73	227.73

MarketScreener's Technical Analysis Ratings

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes

Stock Market
Stocks
ABBV Stock
Charts AbbVie Inc.

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!